What is Pasithea Therapeutics Corp. Common Stock's Market Cap?

Pasithea Therapeutics Corp. Common Stock's Market Cap is $18.0M, based on as-reported figures from SEC (XBRL) filings.

What is Pasithea Therapeutics Corp. Common Stock's Enterprise Value?

Pasithea Therapeutics Corp. Common Stock's Enterprise Value is -$37.1M, based on as-reported figures from SEC (XBRL) filings.

What is Pasithea Therapeutics Corp. Common Stock's EV / EBITDA?

Pasithea Therapeutics Corp. Common Stock's EV / EBITDA is 1.8×, based on as-reported figures from SEC (XBRL) filings.

What is Pasithea Therapeutics Corp. Common Stock's Net Income (TTM)?

Pasithea Therapeutics Corp. Common Stock's Net Income (TTM) is -$20.4M, based on as-reported figures from SEC (XBRL) filings.

What is Pasithea Therapeutics Corp. Common Stock's EBITDA?

Pasithea Therapeutics Corp. Common Stock's EBITDA is -$20.8M, based on as-reported figures from SEC (XBRL) filings.

What is Pasithea Therapeutics Corp. Common Stock's Diluted EPS (TTM)?

Pasithea Therapeutics Corp. Common Stock's Diluted EPS (TTM) is -0.61, based on as-reported figures from SEC (XBRL) filings.

What is Pasithea Therapeutics Corp. Common Stock's Net Debt?

Pasithea Therapeutics Corp. Common Stock's Net Debt is -$55.2M, based on as-reported figures from SEC (XBRL) filings.

Pasithea Therapeutics Corp. Common Stock (KTTA) Financial Statements

Pasithea Therapeutics Corp. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG01018ZHS3

XNAS · usd

0.54▼ 0.03 (-5.21%)

As of 2026-09-10

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close0.57

Day's Range0.52 – 0.58

52-Week Range0.28 – 2.06

Volume246.8K

Avg Volume224.2K

Share Statistics

Shares Outstanding

Employees5

ExchangeXNAS

Listed2021-09-15

Share count as of August 12, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Pasithea Therapeutics Corp. Common Stock (KTTA)

What is Pasithea Therapeutics Corp. Common Stock's Market Cap?: Pasithea Therapeutics Corp. Common Stock's Market Cap is $18.0M, based on as-reported figures from SEC (XBRL) filings.
What is Pasithea Therapeutics Corp. Common Stock's Enterprise Value?: Pasithea Therapeutics Corp. Common Stock's Enterprise Value is -$37.1M, based on as-reported figures from SEC (XBRL) filings.
What is Pasithea Therapeutics Corp. Common Stock's EV / EBITDA?: Pasithea Therapeutics Corp. Common Stock's EV / EBITDA is 1.8×, based on as-reported figures from SEC (XBRL) filings.
What is Pasithea Therapeutics Corp. Common Stock's Net Income (TTM)?: Pasithea Therapeutics Corp. Common Stock's Net Income (TTM) is -$20.4M, based on as-reported figures from SEC (XBRL) filings.
What is Pasithea Therapeutics Corp. Common Stock's EBITDA?: Pasithea Therapeutics Corp. Common Stock's EBITDA is -$20.8M, based on as-reported figures from SEC (XBRL) filings.
What is Pasithea Therapeutics Corp. Common Stock's Diluted EPS (TTM)?: Pasithea Therapeutics Corp. Common Stock's Diluted EPS (TTM) is -0.61, based on as-reported figures from SEC (XBRL) filings.
What is Pasithea Therapeutics Corp. Common Stock's Net Debt?: Pasithea Therapeutics Corp. Common Stock's Net Debt is -$55.2M, based on as-reported figures from SEC (XBRL) filings.